Introduction
Barkan Pharma Israel Ltd. is a privately held pharmaceutical company.
The company specializes in the development, production and marketing of ethical drugs.
The company's drug is currently being marketing and investigated in Eastern Europe, in order to create a fast track to embark the Western world.
The Company was established in 2010 by Mr. Refael Barkan, the founder of Aminolab Ltd., Israel's leading analytical laboratory services company.
Barkan Pharma Israel developed several innovative therapies that have been clinically tested and proven to be safe and highly effective.
Products
Raviset ®
New effective & safe drug to treat pain and excessive bleeding during menstrual period.
Development of highly effective, safety products to treat pain and bleeding of primary and secondary dysmenorrhea in women with heavy menstrual bleeding (HMB).
strategy
The business strategy of Barkan Pharma is based on the continued clinical development of the leading drug Raviset® for marketing approval in Western countries (FDA or the equivalent European authorities).
Simultaneously BARKAN PHARMA ISRAEL is developing the markets in Eastern European and other countries in the Far East.
The company has already started to operate in the markets that do not require FDA approval.
Raviset® is already registered in Moldova, as a treatment for pain & Excessive bleeding during menstrual period.